Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinguan Lin

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Cancer Science|November 16, 2022
LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1-p53/c-Myc axisLinda Oyang, Lei Ouyang, Lixia Yang, et al.
International Journal of Biological Sciences|February 22, 2024
Diallyl disulfide induces DNA damage and growth inhibition in colorectal cancer cells by promoting POU2F1 ubiquitinationLongzheng Xia, Jinguan Lin, Mingjing Peng, et al.
Cell Death Discovery|July 30, 2024
Endoplasmic reticulum stress-a key guardian in cancerWenlong Zhang, Yidan Shi, Linda Oyang, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 10, 2023
Exosomal cargos-mediated metabolic reprogramming in tumor microenvironmentShiming Tan, Yiqing Yang, Wenjuan Yang, et al.
Molecular Therapy Oncolytics|March 14, 2022
Exosomal miR-205-5p enhances angiogenesis and nasopharyngeal carcinoma metastasis by targeting <i>desmocollin-2</i>Wenjuan Yang, Shiming Tan, Lixia Yang, et al.
Cancer Letters|February 1, 2025
Phase Ib study of SCT200 combined with paclitaxel or docetaxel in patients with recurrent or metastatic head and neck squamous cell carcinoma following platinum-based chemotherapy and PD-1 antibodyJinguan Lin, Song Qu, Kunyu Yang, et al.
Signal Transduction and Targeted Therapy|June 8, 2026
Efficacy and safety of toripalimab in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): a phase 1b/2 studyYe Guo, Zhendong Li, Liqiong Xue, et al.
Hepatobiliary Surgery and Nutrition|June 11, 2026
Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition)Zheng Wang, Huichuan Sun, Jian Zhou, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Cancer Science|November 16, 2022
LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1-p53/c-Myc axisLinda Oyang, Lei Ouyang, Lixia Yang, et al.
International Journal of Biological Sciences|February 22, 2024
Diallyl disulfide induces DNA damage and growth inhibition in colorectal cancer cells by promoting POU2F1 ubiquitinationLongzheng Xia, Jinguan Lin, Mingjing Peng, et al.
Cell Death Discovery|July 30, 2024
Endoplasmic reticulum stress-a key guardian in cancerWenlong Zhang, Yidan Shi, Linda Oyang, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 10, 2023
Exosomal cargos-mediated metabolic reprogramming in tumor microenvironmentShiming Tan, Yiqing Yang, Wenjuan Yang, et al.
Molecular Therapy Oncolytics|March 14, 2022
Exosomal miR-205-5p enhances angiogenesis and nasopharyngeal carcinoma metastasis by targeting <i>desmocollin-2</i>Wenjuan Yang, Shiming Tan, Lixia Yang, et al.
Cancer Letters|February 1, 2025
Phase Ib study of SCT200 combined with paclitaxel or docetaxel in patients with recurrent or metastatic head and neck squamous cell carcinoma following platinum-based chemotherapy and PD-1 antibodyJinguan Lin, Song Qu, Kunyu Yang, et al.
Signal Transduction and Targeted Therapy|June 8, 2026
Efficacy and safety of toripalimab in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): a phase 1b/2 studyYe Guo, Zhendong Li, Liqiong Xue, et al.
Hepatobiliary Surgery and Nutrition|June 11, 2026
Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition)Zheng Wang, Huichuan Sun, Jian Zhou, et al.
Pageof 5